Alpha-1 Antitrypsin Deficiency (A1AD) Global Clinical Trials Review 2024: Overview of Trial Numbers, Top Countries, Trial Status, Trial Phase, Sponsor Type and End Point Status
GlobeNewswire·2025-02-04 14:47
Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides top line data relating to the clinical trials on Alpha-1 Antitrypsin Deficiency (A1AD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial sta ...